Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,027 | 19,926 | 30,674 | 30,975 | 42,855 |
| Marketable Securities | 4,981 | 41,590 | 62,633 | N/A | N/A |
| Receivables | N/A | N/A | N/A | N/A | 7,583 |
| Other current assets | 0 | 0 | 0 | 5,000 | 8,183 |
| TOTAL | $30,010 | $64,437 | $95,963 | $38,275 | $63,186 |
| Non-Current Assets | |||||
| PPE Net | 90 | 113 | N/A | N/A | 354 |
| Other Non-Current Assets | 60 | 2,355 | 1,722 | 2,483 | 3,506 |
| TOTAL | $150 | $2,468 | $1,722 | $2,483 | $3,860 |
| Total Assets | $30,160 | $66,905 | $97,685 | $40,758 | $67,046 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,041 | 2,707 | 1,659 | 2,386 | 6,510 |
| Accrued Expenses | 941 | 9,272 | 4,119 | 4,381 | 8,593 |
| Other current liabilities | 413 | 2,741 | 1,645 | 2,578 | 2,958 |
| TOTAL | $2,395 | $14,819 | $7,538 | $9,345 | $18,410 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 1,412 | 211 | 0 |
| TOTAL | $N/A | $N/A | $1,412 | $211 | $N/A |
| Total Liabilities | $2,395 | $14,819 | $8,950 | $9,556 | $18,410 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,323 | 15,210 | 14,099 | 3,264 | 3,123 |
| Common Shares | 3 | 1 | 1 | 0 | 5 |
| Retained earnings | -757,653 | -731,170 | -691,336 | -662,735 | -639,525 |
| Other shareholders' equity | 2 | 20 | 26 | 0 | 0 |
| TOTAL | $27,765 | $52,086 | $88,735 | $31,202 | $48,636 |
| Total Liabilities And Equity | $30,160 | $66,905 | $97,685 | $40,758 | $67,046 |